文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Preferences for pre-exposure prophylaxis (PrEP) among sexual and gender minorities: a discrete choice experiment in Brazil.

作者信息

Pereira Claudia Cristina de Aguiar, Torres Thiago Silva, Luz Paula Mendes, Hoagland Brenda, Farias Alessandro, Brito José David Urbaez, Lacerda Marcus Vinícius Guimarães, Silva Daila Alena Raenck, Benedetti Marcos, Pimenta Maria Cristina, Grinsztejn Beatriz, Veloso Valdilea Gonçalves

机构信息

Escola Nacional de Saúde Pública Sérgio Arouca - ENSP, FIOCRUZ, Rio de Janeiro, RJ, Brazil.

Laboratório de Pesquisa Clínica em HIV/AIDS (LapClin-AIDS), Instituto Nacional de Infectologia Evandro Chagas - INI, FIOCRUZ, Rio de Janeiro, RJ, Brazil.

出版信息

Lancet Reg Health Am. 2023 Feb 6;19:100432. doi: 10.1016/j.lana.2023.100432. eCollection 2023 Mar.


DOI:10.1016/j.lana.2023.100432
PMID:36950036
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10025414/
Abstract

BACKGROUND: Men who have sex with men (MSM) and transgender women (TGW) are disproportionally affected by HIV infection in Latin America. This study aims to assess pre-exposure prophylaxis (PrEP) preferences among sexual and gender minorities (SGM) and identify attributes and levels that are related to PrEP uptake and adherence, both crucial for PrEP success. METHODS: We conducted a discrete choice experiment (DCE) among SGM from all Brazilian regions (September-December/2020). The survey was administered face-to-face (five Brazilian capitals) and online (entire country). We used a D-efficient zero-prior blocked experimental design to select 60 paired-profile DCE choice tasks. FINDINGS: The total sample size was 3924 (90.5% MSM; 7.2% TGW and 2.3% non-binary or gender diverse persons). In random-effects logit models, highest levels of protection and "no side effects" were the most important attribute levels. For "presentation", injectable and implant were preferred over oral. Participants were willing to accept a 4.1% protection reduction to receive injectable PrEP or a 4.2% reduction if PrEP were taken monthly. The largest class in the latent class models was defined predominantly by the preference for the highest HIV protection level (p < 0.005). Respondents in this class also preferred no side effects, injectable and implant presentations. INTERPRETATION: Higher HIV protection, no side effects, and presentation, whether injectable or implant, were the most important attributes in PrEP preferences. Protection against HIV was the most important attribute. PrEP programs should make available technologies such as long-acting presentations that could reunite the most desired attributes, thus maximizing acceptability and user-appropriateness. FUNDING: Unitaid.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b0/10025414/d5e43e0c4c61/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b0/10025414/dcfb0ee1b3a0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b0/10025414/651d39576bc2/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b0/10025414/d5e43e0c4c61/figs2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b0/10025414/dcfb0ee1b3a0/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b0/10025414/651d39576bc2/figs1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/94b0/10025414/d5e43e0c4c61/figs2.jpg

相似文献

[1]
Preferences for pre-exposure prophylaxis (PrEP) among sexual and gender minorities: a discrete choice experiment in Brazil.

Lancet Reg Health Am. 2023-2-6

[2]
Preferences for pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women at risk of HIV infection: a multicentre protocol for a discrete choice experiment in Brazil.

BMJ Open. 2021-9-27

[3]
Variation in Preferences for Long-Acting Injectable Pre-Exposure Prophylaxis Among US Men Who Have Sex with Men: A Latent Class Analysis.

AIDS Patient Care STDS. 2023-10

[4]
Pre-exposure prophylaxis service among men who have sex with men in Malaysia: findings from a discrete choice experiment.

Sci Rep. 2023-8-30

[5]
Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment.

AIDS Care. 2019-5

[6]
Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.

Lancet HIV. 2023-2

[7]
Optimizing Uptake of Long-Acting Injectable Pre-exposure Prophylaxis for HIV Prevention for Men Who Have Sex with Men.

AIDS Behav. 2023-8

[8]
Engagement in the pre-exposure prophylaxis (PrEP) cascade among a respondent-driven sample of sexually active men who have sex with men and transgender women during early PrEP implementation in Zimbabwe.

J Int AIDS Soc. 2022-2

[9]
Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.

J Int AIDS Soc. 2022-10

[10]
Preferences Among Physicians and Men Who Have Sex with Men (MSM) for a Long-Acting, Removable Implant for HIV Prevention: A Discrete Choice Study.

AIDS Res Hum Retroviruses. 2022-12

引用本文的文献

[1]
Preferences for HIV pre-exposure prophylaxis among men who have sex with men and trans women in 15 countries and territories in Asia and Australia: a discrete choice experiment.

J Int AIDS Soc. 2025-8

[2]
Sexual Orientation and Gender Identity Associated with Sexual Practices, Psychoactive Substance Use and Sexually Transmitted Infections Among HIV PrEP Users.

Healthcare (Basel). 2025-7-29

[3]
Hypothetical Preferences and Concerns for Long-Acting Injectable HIV PrEP Use Among Female Barmaids in Ubungo, Dar Es Salaam, Tanzania.

HIV AIDS (Auckl). 2025-8-7

[4]
Stated preferences of adolescents and young adults for sexual and reproductive health services in Africa: a systematic review.

Sex Reprod Health Matters. 2025-12

[5]
Seizing the moment: the potential of PrEP choice and innovation to transform HIV prevention.

J Int AIDS Soc. 2025-7

[6]
Awareness and intention to use event-driven and long-acting injectable pre-exposure prophylaxis among adolescent and young men who have sex with men and transgender women in Brazil: a cross-sectional study.

J Int AIDS Soc. 2025-7

[7]
Exploring perceptions and preferences for PrEP choice and of an mHealth intervention: insights from the ImPrEP CAB-Brasil study.

J Int AIDS Soc. 2025-7

[8]
Lenacapavir: a potential game changer for HIV prevention in the Americas, if the game is played equitably.

Lancet Reg Health Am. 2025-6-10

[9]
The Evolving Landscape of Discrete Choice Experiments in Health Economics: A Systematic Review.

Pharmacoeconomics. 2025-5-21

[10]
Preventing Premature Pre-Exposure Prophylaxis Discontinuation and Sexually Transmitted Infections Among Men Who Have Sex With Men (Project PEACH): Protocol for a Prospective Cohort Study.

JMIR Res Protoc. 2025-4-23

本文引用的文献

[1]
Same-day initiation of oral pre-exposure prophylaxis among gay, bisexual, and other cisgender men who have sex with men and transgender women in Brazil, Mexico, and Peru (ImPrEP): a prospective, single-arm, open-label, multicentre implementation study.

Lancet HIV. 2023-2

[2]
Factors associated with long-term HIV pre-exposure prophylaxis engagement and adherence among transgender women in Brazil, Mexico and Peru: results from the ImPrEP study.

J Int AIDS Soc. 2022-10

[3]
Low PrEP adherence despite high retention among transgender women in Brazil: the PrEParadas study.

J Int AIDS Soc. 2022-3

[4]
High Rates of Sexualized Drug Use or Chemsex among Brazilian Transgender Women and Young Sexual and Gender Minorities.

Int J Environ Res Public Health. 2022-2-2

[5]
Preferences regarding emerging HIV prevention technologies among Toronto men who have sex with men: a discrete choice experiment.

Sci Rep. 2021-11-15

[6]
Preferences for pre-exposure prophylaxis (PrEP) among men who have sex with men and transgender women at risk of HIV infection: a multicentre protocol for a discrete choice experiment in Brazil.

BMJ Open. 2021-9-27

[7]
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women.

N Engl J Med. 2021-8-12

[8]
U.S. transgender women's preferences for microeconomic interventions to address structural determinants of HIV vulnerability: a qualitative assessment.

BMC Public Health. 2021-7-14

[9]
HIV Pre-Exposure Prophylaxis, Condoms, or Both? Insights on Risk Compensation Through a Discrete Choice Experiment and Latent Class Analysis Among Men Who Have Sex With Men.

Value Health. 2021-5

[10]
Willingness to Use Pre-exposure Prophylaxis (PrEP) and Preferences Among Men Who have Sex with Men in Mumbai and Chennai, India: A Discrete Choice Experiment.

AIDS Behav. 2021-10

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索